Versant Venture Management, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 71 filers reported holding OCULAR THERAPEUTIX INC in Q3 2015. The put-call ratio across all filers is 1.76 and the average weighting 0.8%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q4 2020$30,333,000
+79.9%
1,465,384
-33.9%
3.15%
+2.1%
Q3 2020$16,859,000
-99.9%
2,215,3840.0%3.09%
+16.4%
Q2 2020$18,454,145,000
+68.3%
2,215,3840.0%2.65%
-11.8%
Q1 2020$10,966,151,000
+25.3%
2,215,3840.0%3.01%
+14.0%
Q4 2019$8,750,767,000
+29.9%
2,215,3840.0%2.64%
+1.2%
Q3 2019$6,734,767,000
-30.9%
2,215,3840.0%2.61%
-8.2%
Q2 2019$9,747,690,000
+10.8%
2,215,3840.0%2.84%
-2.0%
Q1 2019$8,795,074,000
-0.3%
2,215,3840.0%2.90%
-33.6%
Q4 2018$8,817,228,000
-42.2%
2,215,3840.0%4.36%
-15.8%
Q3 2018$15,241,842,000
+1.9%
2,215,3840.0%5.18%
+11.1%
Q2 2018$14,953,842,000
+3.7%
2,215,3840.0%4.66%
+1.1%
Q1 2018$14,422,150,000
+46.3%
2,215,3840.0%4.61%
-55.5%
Q4 2017$9,858,459,000
-28.8%
2,215,3840.0%10.37%
-1.6%
Q3 2017$13,846,150,000
-32.6%
2,215,3840.0%10.54%
-34.8%
Q2 2017$20,536,610,000
-0.1%
2,215,3840.0%16.15%
+8.0%
Q1 2017$20,558,764,000
+10.9%
2,215,3840.0%14.95%
-17.2%
Q4 2016$18,542,764,000
+21.8%
2,215,3840.0%18.05%
+6.4%
Q3 2016$15,219,688,000
+38.8%
2,215,3840.0%16.97%
+52.7%
Q2 2016$10,966,151,000
-48.8%
2,215,3840.0%11.11%
-28.1%
Q1 2016$21,400,609,000
+3.1%
2,215,3840.0%15.45%
+27.2%
Q4 2015$20,758,148,000
-33.4%
2,215,3840.0%12.15%
-32.0%
Q3 2015$31,148,299,0002,215,38417.86%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2015
NameSharesValueWeighting ↓
SUMMER ROAD LLC 5,618,861$116,310,000100.00%
Opaleye Management Inc. 6,510,000$134,758,00017.60%
DELTEC ASSET MANAGEMENT LLC 2,168,573$44,889,0006.87%
Versant Venture Management, LLC 1,465,384$30,333,0003.15%
GREAT POINT PARTNERS LLC 856,162$17,723,0002.88%
Affinity Asset Advisors, LLC 220,000$4,554,0002.41%
Altium Capital Management LP 303,174$6,276,0002.34%
Endurant Capital Management LP 290,465$6,013,0002.17%
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 50,396$1,043,0001.17%
Lisanti Capital Growth, LLC 366,040$7,577,0001.05%
View complete list of OCULAR THERAPEUTIX INC shareholders